Novartis faces one win, one loss in patent cases over blockbuster heart failure drug
Novartis recorded both a win and a loss last week in patent fights over its blockbuster heart drug Entresto.
On July 6, a federal court …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
